Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome

Published:2001-02 Issue:2 Volume:25 Page:183-185
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Tefferi Ayalew,Elliott Michelle A.,Steensma David P.,Hook C.Christopher,Dispenzieria Angela,Hanson Curtis A.,Schroeder Georgene,Letendre Louis

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference11 articles.

1. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome;Anderson;Blood,1993

2. Efficacy and erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies;Hellstrom-Lindberg;Br. J. Haematol.,1995

3. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol);Capizzi;Eur. J. Cancer,1996

4. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome;List;Blood,1997

5. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-κB/Rel transcription factors;Romano;Blood,1999

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic Syndromes;Hematology;2018

2. Does Amifostine Reduce Metabolic Rate? Effect of the Drug on Gas Exchange and Acute Ventilatory Hypoxic Response in Humans;Pharmaceuticals;2015-04-16

3. Hematopoietic Growth Factors in Myelodysplastic Syndromes;Seminars in Oncology;2011-10

4. Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes;Leukemia Research;2009-09

5. Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia;Hematology;2008-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3